[1] LEVEY AS, CORESH J. Chronic kidney disease. Lancet. 2012;379(9811):165-180.
[2] AL-JAGHBEER M, DEALMEIDA D, BILDERBACK A, et al. Clinical Decision Support for In-Hospital AKI. J Am Soc Nephrol. 2018;29(2):654-660.
[3] HOSTE EA, BAGSHAW SM, BELLOMO R, et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. 2015;41(8):1411-1423.
[4] CORESH J, SELVIN E, STEVENS LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298(17):2038-2047.
[5] ZHANG L, WANG F, WANG L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012;379(9818):815-822.
[6] LIYANAGE T, NINOMIYA T, JHA V, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015;385(9981): 1975-1982.
[7] KESHTKAR S, AZARPIRA N, GHAHREMANI MH. Mesenchymal stem cell-derived extracellular vesicles: novel frontiers in regenerative medicine. Stem Cell Res Ther. 2018;9(1):63.
[8] ZHANG Y, MCNEILL E, TIAN H, et al. Urine derived cells are a potential source for urological tissue reconstruction. J Urol. 2008;180(5):2226-2233.
[9] BHARADWAJ S, LIU G, SHI Y, et al. Multipotential differentiation of human urine-derived stem cells: potential for therapeutic applications in urology. Stem Cells. 2013;31(9):1840-1856.
[10] LAZZERI E, RONCONI E, ANGELOTTI ML, et al. Human Urine-Derived Renal Progenitors for Personalized Modeling of Genetic Kidney Disorders. J Am Soc Nephrol. 2015;26(8):1961-1974.
[11] RAHMAN MS, WRUCK W, SPITZHORN LS, et al. The FGF, TGFβ and WNT axis Modulate Self-renewal of Human SIX2+ Urine Derived Renal Progenitor Cells. Sci Rep. 2020;10(1):739.
[12] VAN NIEL G, D’ANGELO G, RAPOSO G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018;19(4):213-228.
[13] BRUNO S, GRANGE C, DEREGIBUS MC, et al. Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J Am Soc Nephrol. 2009; 20(5):1053-1067.
[14] GATTI S, BRUNO S, DEREGIBUS MC, et al. Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury. Nephrol Dial Transplant. 2011;26(5):1474-1483.
[15] MA J, ZHAO Y, SUN L, et al. Exosomes Derived from Akt-Modified Human Umbilical Cord Mesenchymal Stem Cells Improve Cardiac Regeneration and Promote Angiogenesis via Activating Platelet-Derived Growth Factor D. Stem Cells Transl Med. 2017;6(1):51-59.
[16] LU Z, CHEN Y, DUNSTAN C, et al. Priming Adipose Stem Cells with Tumor Necrosis Factor-Alpha Preconditioning Potentiates Their Exosome Efficacy for Bone Regeneration. Tissue Eng Part A. 2017;23(21-22):1212-1220.
[17] CHEW JRJ, CHUAH SJ, TEO KYW, et al. Mesenchymal stem cell exosomes enhance periodontal ligament cell functions and promote periodontal regeneration. Acta Biomater. 2019;89:252-264.
[18] HU L, WANG J, ZHOU X, et al. Exosomes derived from human adipose mensenchymal stem cells accelerates cutaneous wound healing via optimizing the characteristics of fibroblasts. Sci Rep. 2016;6:32993.
[19] WANG J, YI Y, ZHU Y, et al. Effects of adipose-derived stem cell released exosomes on wound healing in diabetic mice. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2020;34(1):124-131.
[20] CAO L, XU H, WANG G, et al. Extracellular vesicles derived from bone marrow mesenchymal stem cells attenuate dextran sodium sulfate-induced ulcerative colitis by promoting M2 macrophage polarization. Int Immunopharmacol. 2019;72:264-274.
[21] CHEN L, LU FB, CHEN DZ, et al. BMSCs-derived miR-223-containing exosomes contribute to liver protection in experimental autoimmune hepatitis. Mol Immunol. 2018;93:38-46.
[22] BODIN A, BHARADWAJ S, WU S, et al. Tissue-engineered conduit using urine-derived stem cells seeded bacterial cellulose polymer in urinary reconstruction and diversion. Biomaterials. 2010;31(34):8889-8901.
[23] WU S, LIU Y, BHARADWAJ S, et al. Human urine-derived stem cells seeded in a modified 3D porous small intestinal submucosa scaffold for urethral tissue engineering. Biomaterials. 2011;32(5):1317-1326.
[24] BHARADWAJ S, LIU G, SHI Y, et al. Characterization of urine-derived stem cells obtained from upper urinary tract for use in cell-based urological tissue engineering. Tissue Eng Part A. 2011;17(15-16):2123-2132.
[25] GUAN X, MACK DL, MORENO CM, et al. Dystrophin-deficient cardiomyocytes derived from human urine: new biologic reagents for drug discovery. Stem Cell Res. 2014;12(2):467-480.
[26] CHEN AJ, PI JK, HU JG, et al. Identification and characterization of two morphologically distinct stem cell subpopulations from human urine samples. Sci China Life Sci. 2020;63(5):712-723.
[27] DOMINICI M, LE BLANC K, MUELLER I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315-317.
[28] DUAN YR, CHEN BP, CHEN F, et al. Exosomal microRNA-16-5p from human urine-derived stem cells ameliorates diabetic nephropathy through protection of podocyte. J Cell Mol Med. 2021;25(23):10798-10813.
[29] OUYANG B, SUN X, HAN D, et al. Human urine-derived stem cells alone or genetically-modified with FGF2 Improve type 2 diabetic erectile dysfunction in a rat model. PLoS One. 2014;9(3):e92825.
[30] PEI M, LI J, ZHANG Y, et al. Expansion on a matrix deposited by nonchondrogenic urine stem cells strengthens the chondrogenic capacity of repeated-passage bone marrow stromal cells. Cell Tissue Res. 2014;356(2):391-403.
[31] HE W, ZHU W, CAO Q, et al. Generation of Mesenchymal-Like Stem Cells From Urine in Pediatric Patients. Transplant Proc. 2016;48(6):2181-2185.
[32] CHEN L, LI L, XING F, et al. Human Urine-Derived Stem Cells: Potential for Cell-Based Therapy of Cartilage Defects. Stem Cells Int. 2018;2018:4686259.
[33] LANG R, LIU G, SHI Y, et al. Self-renewal and differentiation capacity of urine-derived stem cells after urine preservation for 24 hours. PLoS One. 2013;8(1):e53980.
[34] LIU G, WU R, YANG B, et al. Human Urine-Derived Stem Cell Differentiation to Endothelial Cells with Barrier Function and Nitric Oxide Production. Stem Cells Transl Med. 2018;7(9):686-698.
[35] KANG HS, CHOI SH, KIM BS, et al. Advanced Properties of Urine Derived Stem Cells Compared to Adipose Tissue Derived Stem Cells in Terms of Cell Proliferation, Immune Modulation and Multi Differentiation. J Korean Med Sci. 2015;30(12):1764-1776.
[36] KIM K, GIL M, DAYEM AA, et al. Improved Isolation and Culture of Urine-Derived Stem Cells (USCs) and Enhanced Production of Immune Cells from the USC-Derived Induced Pluripotent Stem Cells. J Clin Med. 2020;9(3):827.
[37] YANG X, XIONG X, ZHOU W, et al. Effects of human urine-derived stem cells on the cementogenic differentiation of indirectly-cocultured periodontal ligament stem cells. Am J Transl Res. 2020;12(2):361-378.
[38] TOH WS, LAI RC, ZHANG B, et al. MSC exosome works through a protein-based mechanism of action. Biochem Soc Trans. 2018;46(4):843-853.
[39] LI X, LIAO J, SU X, et al. Human urine-derived stem cells protect against renal ischemia/reperfusion injury in a rat model via exosomal miR-146a-5p which targets IRAK1. Theranostics. 2020;10(21):9561-9578.
[40] ZHANG Y, WANG J, YANG B, et al. Transfer of MicroRNA-216a-5p From Exosomes Secreted by Human Urine-Derived Stem Cells Reduces Renal Ischemia/Reperfusion Injury. Front Cell Dev Biol. 2020;8:610587.
[41] JIANG ZZ, LIU YM, NIU X, et al. Exosomes secreted by human urine-derived stem cells could prevent kidney complications from type I diabetes in rats. Stem Cell Res Ther. 2016;7:24.
[42] CHEN CY, RAO SS, TAN YJ, et al. Extracellular vesicles from human urine-derived stem cells prevent osteoporosis by transferring CTHRC1 and OPG. Bone Res. 2019;7:18.
[43] CHEN CY, DU W, RAO SS, et al. Extracellular vesicles from human urine-derived stem cells inhibit glucocorticoid-induced osteonecrosis of the femoral head by transporting and releasing pro-angiogenic DMBT1 and anti-apoptotic TIMP1. Acta Biomater. 2020;111:208-220.
[44] GUO Z, SU W, ZHOU R, et al. Exosomal MATN3 of Urine-Derived Stem Cells Ameliorates Intervertebral Disc Degeneration by Antisenescence Effects and Promotes NPC Proliferation and ECM Synthesis by Activating TGF-β. Oxid Med Cell Longev. 2021;2021:5542241.
[45] WU R, HUANG C, WU Q, et al. Exosomes secreted by urine-derived stem cells improve stress urinary incontinence by promoting repair of pubococcygeus muscle injury in rats. Stem Cell Res Ther. 2019;10(1):80.
[46] ZHU Q, LI Q, NIU X, et al. Extracellular Vesicles Secreted by Human Urine-Derived Stem Cells Promote Ischemia Repair in a Mouse Model of Hind-Limb Ischemia. Cell Physiol Biochem. 2018;47(3):1181-1192.
[47] WU S, WANG Z, BHARADWAJ S, et al. Implantation of autologous urine derived stem cells expressing vascular endothelial growth factor for potential use in genitourinary reconstruction. J Urol. 2011;186(2):640-647.
[48] CHUN SY, KIM HT, LEE JS, et al. Characterization of urine-derived cells from upper urinary tract in patients with bladder cancer. Urology. 2012;79(5): 1186.e1-7.
[49] LIU G, PARETA RA, WU R, et al. Skeletal myogenic differentiation of urine-derived stem cells and angiogenesis using microbeads loaded with growth factors. Biomaterials. 2013;34(4):1311-1326.
[50] LIU G, WANG X, SUN X, et al. The effect of urine-derived stem cells expressing VEGF loaded in collagen hydrogels on myogenesis and innervation following after subcutaneous implantation in nude mice. Biomaterials. 2013;34(34):8617-8629.
[51] LEE JN, CHUN SY, LEE HJ, et al. Human Urine-derived Stem Cells Seeded Surface Modified Composite Scaffold Grafts for Bladder Reconstruction in a Rat Model. J Korean Med Sci. 2015;30(12):1754-1763.
[52] DONG X, ZHANG T, LIU Q, et al. Beneficial effects of urine-derived stem cells on fibrosis and apoptosis of myocardial, glomerular and bladder cells. Mol Cell Endocrinol. 2016;427:21-32.
[53] 赵雅培,刘翠景,杨翠英,等.人尿源干细胞移植治疗慢性肾病大鼠[J].中国组织工程研究,2016,20(32):4838-4844.
[54] WANG Q, ZHAO J, WU C, et al. Large conductance voltage and Ca2+-activated K+ channels affect the physiological characteristics of human urine-derived stem cells. Am J Transl Res. 2017;9(4):1876-1885.
[55] LI J, LUO H, DONG X, et al. Therapeutic effect of urine-derived stem cells for protamine/lipopolysaccharide-induced interstitial cystitis in a rat model. Stem Cell Res Ther. 2017;8(1):107.
[56] TIAN SF, JIANG ZZ, LIU YM, et al. Human urine-derived stem cells contribute to the repair of ischemic acute kidney injury in rats. Mol Med Rep. 2017; 16(4):5541-5548.
[57] CHOI JY, CHUN SY, HA YS, et al. Potency of Human Urine-Derived Stem Cells for Renal Lineage Differentiation. Tissue Eng Regen Med. 2017;14(6):775-785.
[58] WAN Q, XIONG G, LIU G, et al. Urothelium with barrier function differentiated from human urine-derived stem cells for potential use in urinary tract reconstruction. Stem Cell Res Ther. 2018;9(1):304.
[59] ZHAO Z, LIU D, CHEN Y, et al. Ureter tissue engineering with vessel extracellular matrix and differentiated urine-derived stem cells. Acta Biomater. 2019;88:266-279.
[60] CHUNG JW, CHUN SY, LEE EH, et al. Verification of mesenchymal stem cell injection therapy for interstitial cystitis in a rat model. PLoS One. 2019; 14(12):e0226390.
[61] SUN B, LUO X, YANG C, et al. Therapeutic Effects of Human Urine-Derived Stem Cells in a Rat Model of Cisplatin-Induced Acute Kidney Injury In Vivo and In Vitro. Stem Cells Int. 2019;2019:8035076.
[62] SUN B, DONG X, ZHAO J, et al. Differentiation of human urine-derived stem cells into interstitial cells of Cajal-like cells by exogenous gene modification: A preliminary study. Biochem Biophys Res Commun. 2020;523(1):10-17.
[63] ZHANG C, GEORGE SK, WU R, et al. Reno-protection of Urine-derived Stem Cells in A Chronic Kidney Disease Rat Model Induced by Renal Ischemia and Nephrotoxicity. Int J Biol Sci. 2020;16(3):435-446.
[64] XIONG G, TAO L, MA WJ, et al. Urine-derived stem cells for the therapy of diabetic nephropathy mouse model. Eur Rev Med Pharmacol Sci. 2020; 24(3):1316-1324.
[65] SUN G, DING B, WAN M, et al. Formation and optimization of three-dimensional organoids generated from urine-derived stem cells for renal function in vitro. Stem Cell Res Ther. 2020;11(1):309.
[66] GUO H, DENG N, DOU L, et al. 3-D Human Renal Tubular Organoids Generated from Urine-Derived Stem Cells for Nephrotoxicity Screening. ACS Biomater Sci Eng. 2020;6(12):6701-6709.
[67] KHWAJA A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):c179-184.
[68] LAMEIRE NH, LEVIN A, KELLUM JA, et al. Harmonizing acute and chronic kidney disease definition and classification: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference. Kidney Int. 2021;100(3):516-526.
[69] QI C, MAO X, ZHANG Z, et al. Classification and Differential Diagnosis of Diabetic Nephropathy. J Diabetes Res. 2017;2017:8637138.
[70] STEVENS M, OLTEAN S. Modulation of VEGF-A Alternative Splicing as a Novel Treatment in Chronic Kidney Disease. Genes (Basel). 2018;9(2):98.
[71] NAKAGAWA T, KOSUGI T, HANEDA M, et al. Abnormal angiogenesis in diabetic nephropathy. Diabetes. 2009;58(7):1471-1478.
[72] MOON KH, KO IK, YOO JJ, et al. Kidney diseases and tissue engineering. Methods. 2016;99:112-119.
[73] NISHINAKAMURA R. Human kidney organoids: progress and remaining challenges. Nat Rev Nephrol. 2019;15(10):613-624.
[74] QIN H, ZHU C, AN Z, et al. Silver nanoparticles promote osteogenic differentiation of human urine-derived stem cells at noncytotoxic concentrations. Int J Nanomedicine. 2014;9:2469-2478.
[75] GUAN J, ZHANG J, LI H, et al. Human Urine Derived Stem Cells in Combination with β-TCP Can Be Applied for Bone Regeneration. PLoS One. 2015;10(5):e0125253.
[76] CHUN SY, KIM HT, KWON SY, et al. The efficacy and safety of Collagen-I and hypoxic conditions in urine-derived stem cell ex vivo culture. Tissue Eng Regen Med. 2016;13(4):403-415.
|